Javascript must be enabled to continue!
Characterization of a new Pseudomonas aeruginosa Queuovirinae bacteriophage
View through CrossRef
ABSTRACT
The ESKAPEE pathogen
Pseudomonas aeruginosa
is a common cause of chronic wound and cystic fibrosis lung infections, as well as acute burn and nosocomial infections. Many of these infections are recalcitrant to conventional antibiotic therapies due to both traditional antibiotic resistance mechanisms and antimicrobial tolerance. Recent successes with bacteriophage (phage) therapy to treat chronic human
P. aeruginosa
infections have led to a renewed interest in isolating and characterizing new
P. aeruginosa
phages. Here, we isolated and characterized a new lytic phage (termed PIP, pili-infecting phage) capable of infecting
P. aeruginosa
PA14. PIP is a tailed phage with an icosahedral head and flexible tail containing a genome that is 57,462 bp in length. Phylogenetic analysis reveals that PIP belongs to the subfamily Queuovirinae and genus Nipunavirus but is highly divergent in gene content from known Nipunaviruses. By isolating and characterizing a
P. aeruginosa
strain that spontaneously evolved resistance to PIP, we show that the receptor for PIP is Type IV pili. In summary, we isolated a new
P. aeruginosa
phage species with a unique genome, thus increasing the diversity of phages known to infect this important human pathogen.
IMPORTANCE
The opportunistic pathogen
Pseudomonas aeruginosa
causes both acute and chronic human infections. These infections are notoriously difficult to treat due to both antibiotic resistance and antibiotic tolerance. The increasing frequency of antibiotic failure in
P. aeruginosa
infections has led scientists to explore other treatment options, including bacteriophage (phage) therapy. To this end, there has been a significant effort to identify new
Pseudomonas
phages. Here, we isolated and characterized a bacteriophage (termed PIP, pili-infecting phage) that infects
P. aeruginosa
PA14. Examination of the PIP genome revealed that this phage represents a new species in the subclass Queuovirinae. The isolation and characterization of spontaneous PA14 mutants that are resistant to PIP infection revealed Type IV pili as the PIP receptor. Ultimately, this study characterizes a new species of
Pseudomonas
phage, thus enhancing the known diversity of phages that infect this important pathogen.
Title: Characterization of a new
Pseudomonas aeruginosa
Queuovirinae bacteriophage
Description:
ABSTRACT
The ESKAPEE pathogen
Pseudomonas aeruginosa
is a common cause of chronic wound and cystic fibrosis lung infections, as well as acute burn and nosocomial infections.
Many of these infections are recalcitrant to conventional antibiotic therapies due to both traditional antibiotic resistance mechanisms and antimicrobial tolerance.
Recent successes with bacteriophage (phage) therapy to treat chronic human
P.
aeruginosa
infections have led to a renewed interest in isolating and characterizing new
P.
aeruginosa
phages.
Here, we isolated and characterized a new lytic phage (termed PIP, pili-infecting phage) capable of infecting
P.
aeruginosa
PA14.
PIP is a tailed phage with an icosahedral head and flexible tail containing a genome that is 57,462 bp in length.
Phylogenetic analysis reveals that PIP belongs to the subfamily Queuovirinae and genus Nipunavirus but is highly divergent in gene content from known Nipunaviruses.
By isolating and characterizing a
P.
aeruginosa
strain that spontaneously evolved resistance to PIP, we show that the receptor for PIP is Type IV pili.
In summary, we isolated a new
P.
aeruginosa
phage species with a unique genome, thus increasing the diversity of phages known to infect this important human pathogen.
IMPORTANCE
The opportunistic pathogen
Pseudomonas aeruginosa
causes both acute and chronic human infections.
These infections are notoriously difficult to treat due to both antibiotic resistance and antibiotic tolerance.
The increasing frequency of antibiotic failure in
P.
aeruginosa
infections has led scientists to explore other treatment options, including bacteriophage (phage) therapy.
To this end, there has been a significant effort to identify new
Pseudomonas
phages.
Here, we isolated and characterized a bacteriophage (termed PIP, pili-infecting phage) that infects
P.
aeruginosa
PA14.
Examination of the PIP genome revealed that this phage represents a new species in the subclass Queuovirinae.
The isolation and characterization of spontaneous PA14 mutants that are resistant to PIP infection revealed Type IV pili as the PIP receptor.
Ultimately, this study characterizes a new species of
Pseudomonas
phage, thus enhancing the known diversity of phages that infect this important pathogen.
Related Results
2049. National Trends in Infections caused by Pseudomonas aeruginosa and Carbapenem Resistant Pseudomonas aeruginosa, 2017 – 2020
2049. National Trends in Infections caused by Pseudomonas aeruginosa and Carbapenem Resistant Pseudomonas aeruginosa, 2017 – 2020
Abstract
Background
Pseudomonas aeruginosa is an opportunistic pathogen commonly found in the environment, including water and p...
Prevalence and risk factors of Pseudomonas aeruginosa colonization
Prevalence and risk factors of Pseudomonas aeruginosa colonization
AbstractPseudomonas aeruginosa (P. aeruginosa) is one of the most concerning pathogens due to its multidrug resistance. P. aeruginosa can be a part of the normal commensal flora of...
A Study of Isolation and Identification of Multidrug Resistant Pseudomonas aeruginosa from Wound Specimen
A Study of Isolation and Identification of Multidrug Resistant Pseudomonas aeruginosa from Wound Specimen
Background: Pseudomonas aeruginosa is a clinically important pathogenic microbe in hospitalized patients. It is a major cause of mortality and morbidity having a number of mechanis...
Secondary metabolites produced during Aspergillus fumigatus and Pseudomonas aeruginosa biofilm formation
Secondary metabolites produced during Aspergillus fumigatus and Pseudomonas aeruginosa biofilm formation
AbstractIn Cystic Fibrosis (CF), mucus plaques are formed in the patient’s lung, creating a hypoxic condition and a propitious environment for colonization and persistence of many ...
Multi-drug resistance and nosocomial infections of Acinetobacter baumannii and Pseudomonas aeruginosa among patients hospitalized at Felegehiwot Referral Hospital, Northwest Ethiopia: A cross-sectional study
Multi-drug resistance and nosocomial infections of Acinetobacter baumannii and Pseudomonas aeruginosa among patients hospitalized at Felegehiwot Referral Hospital, Northwest Ethiopia: A cross-sectional study
Abstract
Background:Multi-drug resistant(MDR) Acinetobacter baumannii and Pseudomonas aeruginosa are major causes of nosocomial infections globally. They are the current Wo...
Evaluation of Multi-antibiotic Resistance Index (MAR) and Molecular Characterization of Pseudomonas aeruginosa Isolated in Pathological Products from Chad
Evaluation of Multi-antibiotic Resistance Index (MAR) and Molecular Characterization of Pseudomonas aeruginosa Isolated in Pathological Products from Chad
Pseudomonas aeruginosa is a bacterium present in several ecological niches causing opportunistic infections in humans. In developing countries like Chad, this bacteria is responsib...
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Abstract
Introduction
Hospitals are high-risk environments for infections. Despite the global recognition of these pathogens, few studies compare microorganisms from community-acqu...
Efficient Reduction of Pseudomonas aeruginosa Biofilms Using the Myoviridae Lytic Bacteriophage vBPaeM MLG
Efficient Reduction of Pseudomonas aeruginosa Biofilms Using the Myoviridae Lytic Bacteriophage vBPaeM MLG
Pseudomonas aeruginosa biofilm infections pose significant challenges in clinical settings due to their increased resistance to conventional antibiotics. Bacteriophages, viruses th...


